Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10

OBJECTIVE: There are no validated approaches to predict benefit from adjuvant chemotherapy for resected patients with non-small-cell lung cancer (NSCLC). The aim of this study was to translate a 15-gene mRNA expression profile published by Zhu et al, shown to be prognostic and predictive of benefit,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grieve, Stacy, Ding, Keyue, Moore, Jonathan, Finniss, Mathew, Ray, Ayush, Lees, Miranda, Hossain, Faisal, Murugesan, Alli, Agar, Jane, Acar, Cenk, Taylor, James, Shepherd, Frances A, Reiman, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174014/
https://www.ncbi.nlm.nih.gov/pubmed/32220948
http://dx.doi.org/10.1136/esmoopen-2020-000679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174014/
https://www.ncbi.nlm.nih.gov/pubmed/32220948
http://dx.doi.org/10.1136/esmoopen-2020-000679

Ejemplares similares